Radiotherapy & Oncology
Volume 96, Issue 3 , Pages 302-307, September 2010

Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology

  • John A. Lee

      Affiliations

    • Corresponding Author InformationAddress: Centre for molecular imaging and experimental radiotherapy (IMRE 5469), Université catholique de Louvain, Avenue Hippocrate 55/5469, B-1200 Brussels, Belgium.

Centre for Molecular Imaging and Experimental Radiotherapy (IMRE 5469), Université catholique de Louvain, Brussels, Belgium

Received 9 June 2010; received in revised form 7 July 2010; accepted 7 July 2010. published online 13 August 2010.

Abstract 

Positron emission tomography can be used in radiation oncology for the delineation of target volumes in the treatment planning stage. Numerous publications deal with this topic and the scientific community has investigated many methodologies, ranging from simple uptake thresholding to very elaborate probabilistic models. Nevertheless, no consensus seems to emerge. This paper reviews delineation techniques that are popular in the literature. Special attention is paid to threshold-based techniques and the caveats of this methodology are pointed out by formal analysis. Next, a simple model of positron emission tomography is suggested in order to shed some light on the difficulties of target delineation and how they might be eventually overcome. Validation aspects are considered as well. Finally, a few recommendations are gathered in the conclusion.

Keywords: Radiation oncology, Positron emission tomography, Image segmentation, Target delineation, Uptake threshold, Validation methodology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(10)00386-5

doi:10.1016/j.radonc.2010.07.003

Radiotherapy & Oncology
Volume 96, Issue 3 , Pages 302-307, September 2010